Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies

Arthritis Care and Research

Volumn 53, Issue 2, 2005, Pages 173-177

  Takken, Tim ^a   Van Der Net, Janjaap ^a   Helders, Paul J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adolescents; Children; Exercise test; Exercise tolerance; Juvenile dermatomyositis; Juvenile polymyositis; Short term muscle power

Indexed keywords

ADOLESCENT; ADULT; ANAEROBIC METABOLISM; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE DURATION; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; JUVENILE ONSET IDIOPATHIC INFLAMMATORY MYOPATHY; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; SCHOOL CHILD; SKINFOLD THICKNESS;

ADOLESCENT; ADULT; ANAEROBIOSIS; CHILD; DERMATOMYOSITIS; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEASIBILITY STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MUSCLE, SKELETAL; QUESTIONNAIRES; TIME FACTORS;

EID: 17244380399     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21066     Document Type: Article

References (36)

1. Steinitz H, Steinfeld F. Untersuchungen zum Kreatinstoffwechsel bei Dermatomyositis. Zeitschrift fuer die Gesamte Experimentelle Medizin 1931;79:319-28.
2. Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000;43;2359-67.
3. Niermann KJ, Olsen NJ, Park JH. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis. Arthritis Rheum 2002;46:475-88.
4. Newman ED, Kurland RJ. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis: altered energy utilization during exercise. Arthritis Rheum 1992;35:199-203.
5. Sabina RL, Sulaiman AR, Wortmann RL. Molecular analysis of acquired myoadenylate deaminase deficiency in polymyositis (idiopathic inflammatory myopathy). Adv Exp Med Biol 1991;309B:203-5.
6. Hilario MO, Yamashita H, Lutti D, Len C, Terreri MT, Lederman H. Juvenile idiopathic inflammatory myopathies: the value of magnetic resonance imaging in the detection of muscle involvement. Sao Paulo Med J 2000;118:35-40.
7. Takken T, Spermon N, Helders PJ, Prakken AB, van der Net J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003;30:1075-80.
8. Bar-Or O. The Wingate anaerobic test: an update on methodology, reliability and validity. Sports Med 1987;4:381-94.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
10. Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, King KK. Course of treated juvenile dermatomyositis. J Pediatr 1984;105:399-408.
11. Latin RW. Surface anatomy. In: Roitman JL, editor. ACSM's resource manual for guidelines for exercise testing and prescription. 3rd ed. Baltimore: Williams and Wilkins; 1998. p. 89-100.
12. Pollack ML, Schmidt DH, Jackson AS. Measurement of cardio-respiratory fitness and body composition in the clinical setting. Compr Ther 1980;6:12-27.
13. Wulffraat N, van der Net JJ, Ruperto N, Kamphuis S, Prakken BJ, Ten Cate R, et al. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19Suppl 23:S111-5.
14. Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:71-4.
15. Beenakker EA, van der Hoeven JH, Fock JM, Maurits NM. Reference values of maximum isometric muscle force obtained in 270 children aged 4-16 years by hand-held dynamometry. Neuromuscul Disord 2001;11:441-6.
16. Bohannon RW. Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 1997;78:26-32.
17. Lode. Wingate software. In. Version 1.09 for DOS ed. Groningen, the Netherlands: Lode B.V.; 1999.
18. Takken T, Elst E, Spermon N, Helders PJ, Prakken AB, van der Net J. The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:591-5.
19. Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002;47:118-23.
20. Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000;81:1-5.
21. Hebert CA, Byrnes TJ, Baethge BA, Wolf RE, Kinasewitz GT. Exercise limitation in patients with polymyositis. Chest 1990;98:352-7.
22. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
23. McComas AJ, Belanger AY, Garner S, McCartney N. Muscle performance in neuromuscular disorders. In: Jones NL, editor. Human muscle power. Champaign (IL): Human Kinetics; 1986. p. 309-24.
24. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol 2002;85:89-99.
25. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
26. Sharma R, Anker S. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol 2002;85:161-71.
27. Drinkard BE, Hicks J, Danoff J, Rider LG. Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy. Can J Appl Physiol 2003;28:888-97.
28. Bailey RC, Olson J, Pepper SL, Porszasz J, Barstow TJ, Cooper DM. The level and tempo of children's physical activities: an observational study. Med Sci Sports Exerc 1995;27:1033-41.
29. Takken T, van der Net J, Helders PJ. Relationship between functional ability and physical fitness in juvenile idiopathic arthritis patients. Scand J Rheumatol 2003;32:174-8.
30. Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999;52:854-7.
31. Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998;37:196-200.
32. Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/ dermatomyositis patients. Br J Rheumatol 1998;37:1338-42.
33. Alexanderson H, Stenstrom CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000;29:295-301.
34. Varju C, Petho E, Kutas R, Czirjak L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil 2003;17:83-7.
35. Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med 2002;35:31-5.
36. Esbjornsson-Liljedahl M, Dasmalchi M, Alexanderson H, Stahlberg M, Lundberg IE. Changed muscle morphology in myositis patients following a home exercise program. In: Klarlund Petersen B, Febbraio M, Fleshner M, editors. 6th International Society of Exercise Immunology Symposium; 2003; Copenhagen, Danmark; 2003. p. 47.